about
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in ratsCysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatmentChronic antipsychotic treatment: protracted decreases in phospho-TrkA levels in the rat hippocampusAn aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's diseaseNeutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD MouseEffects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in ratsR-(+) and S-(-) isomers of cotinine augment cholinergic responses in vitro and in vivo.Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and developmentEvaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in ratsNeurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career.Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function.Behavioral defects in chaperone-deficient Alzheimer's disease model mice.Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.Diisopropylfluorophosphate Impairs the Transport of Membrane-Bound Organelles in Rat Cortical AxonsTransglutaminase 2 overexpression induces depressive-like behavior and impaired TrkB signaling in miceDetermination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.Mass spectrometry identifies covalent binding of soman, sarin, chlorpyrifos oxon, diisopropyl fluorophosphate, and FP-biotin to tyrosines on tubulin: a potential mechanism of long term toxicity by organophosphorus agents.An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies.Quantitation of cotinine and its metabolites in rat plasma and brain tissue by hydrophilic interaction chromatography tandem mass spectrometry (HILIC-MS/MS).Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans.Repeated exposures to diisopropylfluorophosphate result in impairments of sustained attention and persistent alterations of inhibitory response control in rats.Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys.Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418.Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine.Alzheimer's disease and age-related memory decline (preclinical)The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seekingAlpha 2A adrenergic receptor agonist, guanfacine, attenuates cocaine-related impairments of inhibitory response control and working memory in animal models.The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeysEffects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and movement of mitochondria in rat cortical neurons.Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicityVariable prenatal stress results in impairments of sustained attention and inhibitory response control in a 5-choice serial reaction time task in rats.Exposure to variable prenatal stress in rats: effects on anxiety-related behaviors, innate and contextual fear, and fear extinction.Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeysPositive allosteric modulator of α7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates.
P50
Q24650678-97F78229-9E9E-47B0-B7B3-0C8C2833E04EQ28395841-17865BCB-BFAA-4B8D-B960-DAF1D63AA6C9Q28477574-EB2B9141-5D6B-4389-ABD8-79BABB3B34F9Q28577430-E9C3266E-FFAA-4305-AC60-0288C0B7EF31Q28581962-B887AAE1-1962-4A2A-ABA1-CFC64CA37873Q30363059-98C9790D-2496-47F6-8F55-9FDF8203AE21Q30391389-EFA71228-D2EA-4E6C-B7BC-E266E8DDBD56Q30392403-2E7C5C14-912C-4FD9-A1A6-85A98F49CEB4Q30414108-F26CC5F2-5688-4B43-858F-2AA3F16F1651Q30416730-85BDBE06-CB93-4AB1-A7D0-098EC9C2BC91Q30455777-DD56D571-1ACB-4C3B-9A50-6032DFD94555Q30462470-6BDA9013-53B0-40DD-A44D-FEBCF9408EA2Q30469648-15CB10F6-25D9-4C25-A5D8-D3C88FED990BQ30476539-276C49C6-CEAC-4207-8AC3-542D78EFB410Q30480449-8B5DE562-AA92-4B5A-8136-1EB252788243Q30717808-8EA08EDC-5F11-4255-94F1-6A6D6714D3A6Q30841720-6B6DE969-29F4-402F-8613-C1E10F4755D9Q33322327-0DA3C77F-FBCB-4AA8-A335-992FFF1617C7Q33337647-F9374A05-FA7D-4FFB-8F2F-6E81F5A7E0CBQ33572408-35EB414B-8D27-4796-ABF3-51CF5540CDA9Q33637189-592EA431-9989-46C7-9478-0D75B9FE3ADEQ33772869-BBCF6A08-63EA-45E7-B27C-B087750C5046Q33905502-3484465C-E57A-43F4-BF56-4C44E1A2C50DQ34132886-DB7BDCEF-2BF9-4186-9BE3-FC9D30CA65D3Q34139402-E38F1648-864D-4BFA-89B3-FC3DA5A331BCQ34280771-D50D6B1B-8B14-4939-A33A-46703DA2F047Q34379738-1E43C0DF-BB69-4B9B-BC36-B4A5A1886EC5Q34425879-2CE86953-290E-4880-8F46-36C008E9BFF8Q34426169-E2E377CD-E289-456A-8E11-49D3FD1EAB6EQ34589245-6C9B8AF4-ECA4-4394-A595-AC19BE56D483Q35041190-75B51C0F-EDB0-46C1-897C-E20C8739E33CQ35087497-EC141FE3-6F24-4434-8386-23457FF90A5AQ35120282-13F94EE4-2658-404D-93C2-FF535689F47CQ35376045-AB474BDE-9F32-4586-A00E-7DC67DDE9920Q35429889-FA27F72A-1C34-40BD-A160-A5509CEFEC23Q35955917-10875D6F-E9F6-402B-AB09-646A89860C5BQ36448887-12FA2E9D-2EBA-41A2-8F26-6F1D83BF9329Q36501074-86A7FEFD-64F3-4AA2-B2D9-E81D31B6E732Q36578017-14E01208-81D4-400A-A984-3C576D04F54CQ36582006-4F654B0B-4A56-4D94-970C-BA71506082EF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alvin V. Terry
@ast
Alvin V. Terry
@en
Alvin V. Terry
@es
Alvin V. Terry
@nl
Alvin V. Terry
@sl
type
label
Alvin V. Terry
@ast
Alvin V. Terry
@en
Alvin V. Terry
@es
Alvin V. Terry
@nl
Alvin V. Terry
@sl
prefLabel
Alvin V. Terry
@ast
Alvin V. Terry
@en
Alvin V. Terry
@es
Alvin V. Terry
@nl
Alvin V. Terry
@sl
P108
P106
P1153
7101719272
P21
P31
P496
0000-0003-2071-4767